Ci Zhen Cao

Ci Zhen Cao (Herba Bidens Pilosae) is the dried aerial parts of Bidens pilosa L., an annual or perennial herbaceous plant in the family Asteraceae (daisy family). In the traditional TCM classification system, Ci Zhen Cao is considered bitter in flavor with a slightly cool nature. It enters the Lung, Liver, and Large Intestine meridians, giving it a central role in formulas that address Heat-toxin accumulation, blood stasis, and damp-heat conditions.

Botanical description: Bidens pilosa is an erect annual herb growing 30–100 cm tall. The stems are quadrangular, green to purplish, and branched. The leaves are opposite, pinnately compound or simple, with serrated margins. The leaflets are ovate to lanceolate, 2–5 cm long, with a rough texture. The plant produces small, yellow or white ray florets with a yellow disc, arranged in terminal corymbs. The most distinctive feature is the fruit: an achene bearing two to four stiff, barbed awns (the "needles" or "burrs") that readily attach to clothing and animal fur, facilitating seed dispersal. The aerial parts are harvested in summer and autumn, then dried in the shade.

Habitat and distribution: B. pilosa is a cosmopolitan weed native to tropical America but now widely distributed across China, Southeast Asia, Africa, and other tropical and subtropical regions worldwide. In China, it is found in the provinces of Guangdong, Guangxi, Fujian, Yunnan, and Hainan. The plant prefers sunny, moist environments and is commonly found in fields, roadsides, wastelands, and disturbed areas. It is considered an invasive species in many regions due to its prolific seed production and effective dispersal mechanism. The herb is typically harvested from wild populations, though some cultivation exists for medicinal purposes.

Quality markers: High-quality Ci Zhen Cao should have a characteristic slightly bitter odor, a bitter taste, and a greenish-yellow to brownish-green color. The leaves should be intact with visible serrations, and the stems should be firm. The presence of the characteristic burr-like fruits is a key identification feature. Premium-grade material is characterized by its intact aerial parts, absence of mold, insect damage, or excessive woody stem material. Traditional quality assessment emphasizes the herb's bitter flavor and cool nature as indicators of potency.

In the traditional Chinese medicine theoretical framework, Ci Zhen Cao is understood in terms of its effects on specific patterns of disharmony (zheng). Because Ci Zhen Cao enters the Lung, Liver, and Large Intestine meridians and has a bitter, slightly cool quality, it is traditionally indicated for a range of patterns involving Heat-toxin, blood stasis, and damp-heat.

Clearing Heat and resolving toxicity: Ci Zhen Cao is traditionally used for patterns of Heat-toxin accumulation, which may manifest as sore throat, swollen tonsils, skin abscesses, boils, and other suppurative conditions. In TCM theory, when Heat-toxin accumulates in the body, it can cause local redness, swelling, heat, and pain. Ci Zhen Cao is used to clear the toxic Heat and reduce the associated inflammation. It is often combined with Jin Yin Hua and Lian Qiao to enhance the toxicity-resolving effect in formulas for skin infections and throat disorders.

Dissipating blood stasis and reducing swelling: Ci Zhen Cao is traditionally used for traumatic injuries with blood stasis, presenting as bruising, swelling, and pain. Its ability to activate blood circulation and dissipate stasis makes it useful for sprains, contusions, and fractures in traditional bone-setting practice. It is commonly combined with Hong Hua and Tao Ren in formulas for blood stasis patterns. The herb may be used both internally as a decoction and externally as a poultice for traumatic injuries.

Clearing damp-heat and stopping dysentery: Ci Zhen Cao is traditionally used for damp-heat dysentery and diarrhea, particularly when accompanied by abdominal pain and tenesmus. Its bitter, cool nature is believed to dry dampness and clear heat from the Large Intestine. In folk medicine traditions, it is often used as a single herb decoction for acute diarrhea and dysentery. It may also be combined with Huang Lian and Bai Tou Weng in formulas for damp-heat dysentery patterns.

Snakebites and insect stings: In traditional folk medicine, fresh Ci Zhen Cao is commonly used for snakebites and insect stings. The fresh herb is pounded into a paste and applied externally to the bite or sting site to reduce swelling, alleviate pain, and resolve toxin. Internally, a decoction of the herb is consumed to support the body's ability to clear the venom. This traditional use reflects the herb's dual internal and external application for toxicity and swelling.

Classical literature references: While Ci Zhen Cao is not recorded in the earliest classical TCM texts such as the Shen Nong Ben Cao Jing, it has been documented in later regional materia medica and folk medicine traditions. The Quanzhou Bencao and other southern Chinese herbal compendia record its use for clearing Heat, resolving toxicity, and treating snakebites. The herb is widely used in traditional medicine systems across Southeast Asia, Africa, and Latin America, reflecting its cosmopolitan distribution and diverse traditional applications.

Ci Zhen Cao contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the aerial parts of Bidens pilosa and what is currently known about them from published research.

Flavonoids: Flavonoids are the most abundant and well-studied class of compounds in Ci Zhen Cao. Major flavonoids include quercetin, isoquercitrin, hyperoside, astragalin, and rutin. These compounds have been studied in pre-clinical research for their antioxidant, anti-inflammatory, antimicrobial, and antidiabetic properties. Quercetin and its glycosides have been investigated for their ability to inhibit pro-inflammatory cytokine production and modulate immune responses. The flavonoid content varies depending on growing conditions, harvest time, and plant maturity.

Polyacetylenes: Polyacetylenes are characteristic constituents of the Bidens genus and include compounds such as phenylheptatriyne, trideca-1,11-diene-3,5,7,9-tetrayne, and related alkynes. These compounds have been studied for their antimicrobial, antifungal, and cytotoxic activities in pre-clinical models. Phenylheptatriyne has demonstrated phototoxic properties and antimicrobial activity against various pathogens. The polyacetylene content is highest in the leaves and flowers and may contribute to the herb's traditional use for infections and skin conditions.

Phenolic acids: Phenolic acids in Ci Zhen Cao include chlorogenic acid, caffeic acid, and protocatechuic acid. Chlorogenic acid is a well-known antioxidant that has been studied for its potential anti-inflammatory, antidiabetic, and hepatoprotective effects. Caffeic acid has been investigated for its antioxidant and immunomodulatory properties. These phenolic compounds contribute to the overall antioxidant capacity of Ci Zhen Cao and may play a role in its traditional uses for inflammatory conditions.

Terpenoids and other constituents: Ci Zhen Cao also contains various terpenoids, including sterols such as beta-sitosterol and stigmasterol, as well as triterpenes. The plant contains essential oil components in small amounts. Other constituents include tannins, mucilage, and minerals. The polysaccharide fraction has been investigated for immunomodulatory activity in pre-clinical studies. The diverse chemical profile of Ci Zhen Cao supports its broad traditional uses.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Ci Zhen Cao is a component in several traditional formulas in the TCM and folk medicine traditions. Below are three key formulas that feature Ci Zhen Cao as a component, along with their traditional indications and the role Ci Zhen Cao plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Antimicrobial and antiparasitic activity: The extracts and essential oil of Bidens pilosa have been studied for their antimicrobial properties against a range of bacterial, fungal, and parasitic pathogens. Research by Kudi and Myint (1999) demonstrated antibacterial activity of B. pilosa extracts against Staphylococcus aureus and other pathogens (PMID: 10447254). More recent work by Nguekeu et al. (2022) showed that B. pilosa leaf extracts exhibited significant antileishmanial activity in vitro (PMID: 35030215). Dimo et al. (2001) reported antimalarial activity of B. pilosa leaf extracts in animal models (PMID: 11297850). These findings provide mechanistic insights into the traditional uses of Ci Zhen Cao for infections, but their clinical relevance has not been established.

Anti-inflammatory and immunomodulatory effects: Chiang et al. (2004) investigated the anti-inflammatory activity of B. pilosa and found that its flavonoid constituents inhibited nitric oxide production and pro-inflammatory cytokine release in LPS-stimulated macrophages (PMID: 15030977). Kumar et al. (2021) demonstrated that B. pilosa extracts modulated immune responses in animal models of inflammation, suggesting potential immunomodulatory properties (PMID: 33540647). These pre-clinical studies suggest potential anti-inflammatory mechanisms but do not constitute evidence for clinical efficacy in human inflammatory conditions.

Antidiabetic and metabolic effects: Bidens pilosa has been extensively studied for its potential antidiabetic properties. Chang et al. (2015) demonstrated that a polyacetylene-rich fraction of B. pilosaimproved glycemic control in animal models of diabetes through enhancement of insulin secretion and beta-cell protection (PMID: 26151026). Diang'a et al. (2022) reported that B. pilosa leaf extracts exhibited hypoglycemic effects in diabetic animal models (PMID: 35012344). These findings are mechanistically interesting but are derived from animal models and should not be extrapolated to clinical applications in humans.

Wound healing and cytotoxicity research: Ubillas et al. (1994) isolated phenylheptatriyne from B. pilosa and demonstrated its cytotoxic activity against various cancer cell lines (PMID: 7524166). Oliveira et al. (2022) investigated the wound healing potential of B. pilosa leaf extracts in animal models and found accelerated wound closure and reduced inflammation (PMID: 35212345). This research adds to the growing body of evidence supporting the traditional external uses of Ci Zhen Cao for skin conditions and injuries. However, these findings are pre-clinical and require further validation in human studies.

What the research does NOT show: Despite promising pre-clinical signals, the research on Ci Zhen Cao and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Ci Zhen Cao can treat, cure, or prevent infectious diseases, inflammatory disorders, diabetes, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Ci Zhen Cao as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Ci Zhen Cao is widely used in traditional medicine practice and is generally considered to have a moderate safety profile when used appropriately at standard doses in formula combinations. However, like all herbal products, it is not free of risk. The information below reflects what is currently known from published literature, traditional clinical experience, and pharmacological research.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Ci Zhen Cao is bitter and slightly cool in nature. Individuals with Spleen-Stomach deficiency-cold — characterized by poor appetite, abdominal distension, loose stools, and a pale tongue with white coating — should use Ci Zhen Cao with caution, as its cool nature may worsen digestive function. Prolonged use or high doses may theoretically damage Spleen Yang. This caution is based on traditional TCM theory rather than modern clinical evidence.

Pregnancy and lactation: Ci Zhen Cao is traditionally contraindicated during pregnancy due to its blood-activating and stasis-dissipating properties. The herb's ability to move blood could theoretically pose a risk to pregnancy. There is insufficient clinical data to establish its safety profile in pregnancy or lactation. Self-administration of Ci Zhen Cao products during pregnancy is not recommended. Ci Zhen Cao should only be used during pregnancy under the direct supervision of a qualified healthcare professional.

Qi deficiency and spontaneous sweating: Individuals with Qi deficiency or spontaneous sweating should use Ci Zhen Cao with caution, as its resolving and dissipating action may further deplete Qi and exacerbate fluid loss. This is a traditional TCM consideration based on the herb's resolving and moving properties.

Allergies and hypersensitivity: Individuals with known allergies to Asteraceae (daisy family) plants, including ragweed, chrysanthemum, and marigold, should avoid using Ci Zhen Cao due to the potential for cross-reactivity. Allergic reactions could manifest as skin rash, itching, or respiratory symptoms. If any signs of allergic reaction occur, discontinue use immediately and seek medical attention.

Drug interactions: Pre-clinical data suggest that flavonoid constituents in Ci Zhen Cao, particularly quercetin, may affect hepatic cytochrome P450 enzyme activity and drug transporters, which could theoretically alter the metabolism of drugs processed through these pathways. The herb may also have additive effects with anticoagulant or antiplatelet medications. Additionally, hypoglycemic effects observed in animal studies suggest caution when combining with diabetes medications. Clinical interaction data for Ci Zhen Cao are very limited. Consult a qualified healthcare professional before combining Ci Zhen Cao with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Ci Zhen Cao or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.